Abnormal expression of RBM8A has been observed in many types of cancer, including cervical cancer, non-small-cell lung carcinoma, myeloma, gastric cancer, and hepatocellular carcinomas (23–26). Here, RBM8A is linked to hepatocellular carcinoma.